Platelet-Rich Plasma-Fibrin Glue
Phase 3Small molecule
Platelet-Rich Plasma-Fibrin Glue is one of 43 small molecule programs targeting Treatment. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
42
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
332 competitors in Treatment
#DrugCompanyPhaseTrials
1Biltricide
BayerPreclinical
Platelet-Rich Plasma-Fibrin Glue
MMashhad University of Medical Sciences
Phase 3
Alfenta
Jazz PharmaceuticalsPreclinical
Niclocide
BayerPreclinical
Minipress
PfizerPreclinical
Theo-Dur
PfizerPreclinical
Levulan
Sun Pharmaceutical Industries, Inc.Preclinical
Hivid
CConrado Roberto Hoffmann Filho
Preclinical
Aurlumyn
BBTG International Inc.
Preclinical
Intuniv
PPromius Pharma, LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details